Wired1 hour agoHealth1 min read
Measles Is Becoming So Common That Treatments May Soon Be Needed
Quick Look
As measles cases in the US reach multi-decade highs due to declining vaccination rates, researchers are actively developing new antiviral treatments for infected individuals and vulnerable populations.
AI-generated summary
Why It Matters
The US is experiencing its highest number of measles cases in decades, coinciding with a decline in vaccination rates.
Font size
As the US sees its highest number of measles cases in decades and vaccination rates fall, researchers are developing drugs to help those who contract the virus or who are particularly vulnerable.
Open Questions
- What specific drugs are currently in development?
- What is the timeline for clinical trials?
Related Topics
PlacesUS
This article was originally published by Wired.
